These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20444587)
1. Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. Hie M; Tsukamoto I J Nutr Biochem; 2011 Feb; 22(2):164-71. PubMed ID: 20444587 [TBL] [Abstract][Full Text] [Related]
2. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. Hie M; Tsukamoto I Eur J Pharmacol; 2011 Oct; 668(1-2):140-6. PubMed ID: 21806983 [TBL] [Abstract][Full Text] [Related]
3. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996 [TBL] [Abstract][Full Text] [Related]
4. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. Kanazawa K; Kudo A J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857 [TBL] [Abstract][Full Text] [Related]
5. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor. Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478 [TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731 [TBL] [Abstract][Full Text] [Related]
8. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H; Guo J; Bringhurst FR J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438 [TBL] [Abstract][Full Text] [Related]
9. Compressive mechanical force augments osteoclastogenesis by bone marrow macrophages through activation of c-Fms-mediated signaling. Cho ES; Lee KS; Son YO; Jang YS; Lee SY; Kwak SY; Yang YM; Park SM; Lee JC J Cell Biochem; 2010 Dec; 111(5):1260-9. PubMed ID: 20803546 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185 [TBL] [Abstract][Full Text] [Related]
11. Fish oil suppresses bone resorption by inhibiting osteoclastogenesis through decreased expression of M-CSF, PU.1, MITF and RANK in ovariectomized rats. Nakanishi A; Iitsuka N; Tsukamoto I Mol Med Rep; 2013 Jun; 7(6):1896-903. PubMed ID: 23625116 [TBL] [Abstract][Full Text] [Related]
12. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment. Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600 [TBL] [Abstract][Full Text] [Related]
14. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis. Merle B; Itzstein C; Delmas PD; Chenu C J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357 [TBL] [Abstract][Full Text] [Related]
15. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. Shin HH; Kim SJ; Kang SY; Lee DS; Choi HS Bone; 2006 Oct; 39(4):716-23. PubMed ID: 16750437 [TBL] [Abstract][Full Text] [Related]
16. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114 [TBL] [Abstract][Full Text] [Related]
17. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Yamaguchi M; Uchiyama S Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020 [TBL] [Abstract][Full Text] [Related]
18. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185 [TBL] [Abstract][Full Text] [Related]
19. Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling. Kook SH; Son YO; Hwang JM; Kim EM; Lee CB; Jeon YM; Kim JG; Lee JC J Cell Biochem; 2009 Apr; 106(6):1010-9. PubMed ID: 19206164 [TBL] [Abstract][Full Text] [Related]
20. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]